Clearone INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
NASDAQ
CLRO
Clearone INCClearOne, Inc. has entered into material definitive agreements with four advisors, compensating them with company stock for past and ongoing advisory services.
NASDAQ
CLRO
Clearone INCClearOne, Inc. announced the cancellation of warrants with First Finance Ltd. and finalized an employment agreement for its CFO, Simon Brewer, effective upon merger completion.
NASDAQ
CLRO
Clearone INCClearOne, Inc. has entered into a definitive agreement to acquire Cortigent, Inc., a subsidiary of Vivani Medical, Inc., in a stock-for-stock merger transaction.
NASDAQ
CLRO
Clearone INCClearOne, Inc. has entered into a loan agreement for up to $1,000,000 to support general working capital needs.
NASDAQ
CLRO
Clearone INCClearOne, Inc. has successfully completed its reincorporation from Delaware to Nevada, effective April 22, 2026.
NASDAQ
CLRO
Clearone INCClearOne, Inc. has terminated its corporate office lease, incurring a $300,000 fee, while simultaneously addressing a notice from Nasdaq regarding continued listing standards.
NASDAQ
CLRO
Clearone INCClearOne, Inc. stockholders approved the company's reincorporation from Delaware to Nevada via written consent, with the change expected to take effect after a 20-day notice period.
NASDAQ
CLRO
Clearone INCClearOne, Inc. repurchased 24,155 common stock purchase warrants from CVI Investments, Inc. for $22,000, effectively cancelling them.
NASDAQ
CLRO
Clearone INCClearOne's Spanish subsidiary resolves wrongful termination claims with eight former employees for a cash payment of €392,809.80.
NASDAQ
CLRO
Clearone INCClearOne's Spanish subsidiary has settled wrongful termination claims with eight former employees for an aggregate cash payment of 392,809.80 euros.
NASDAQ
CLRO
Clearone INCClearOne, Inc. announced new employment agreements for its CEO and CFO, alongside the re-election of all directors and approval of executive compensation at its annual shareholder meeting.
NASDAQ
CLRO
Clearone INCClearOne, Inc. announced the sale of its intellectual property, brands, and product designs to Biamp, outlining transition plans and support for its channel partners and customers.
NASDAQ
CLRO
Clearone INCClearOne, Inc. has completed the sale of a significant portion of its intellectual property and product inventory to Biamp Systems, LLC for $3 million as part of its ongoing strategic process.
NASDAQ
CLRO
Clearone INCClearOne, Inc. repurchased 3,788 common stock warrants for $2,463.72, eliminating potential future dilution.
NASDAQ
CLRO
Clearone INCClearOne, Inc. repurchased 18,940 common stock warrants from its majority stockholder, Edward Dallin Bagley, for an aggregate cash payment of $12,319.
NASDAQ
CLRO
Clearone INCClearOne, Inc. announced the repurchase and cancellation of 24,155 common stock purchase warrants from Lind Global Fund Group II LP for $15,710.41.
NASDAQ
CLRO
Clearone INCClearOne, Inc. repurchased 6,039 common stock purchase warrants from Intracoastal Capital, LLC for an aggregate of $3,927.77.
NASDAQ
CLRO
Clearone INCClearOne, Inc. announced a one-time special stock dividend of Class A Redeemable Preferred Stock, granting legacy stockholders a 100% stake in the net proceeds from a potential future asset sale, with a record date of July 11, 2025.
NASDAQ
CLRO
Clearone INCClearOne, a leader in conferencing solutions, announced a $3 million convertible note investment to support its strategic alternatives process, alongside a workforce restructuring.
NASDAQ
CLRO
Clearone INCClearOne, Inc. announced a special one-time stock dividend of Class A Redeemable Preferred Stock, granting legacy stockholders 100% of net proceeds from a future asset sale.
NASDAQ
CLRO
Clearone INC8-K: ClearOne Secures $3 Million Convertible Note, Initiates Strategic Asset Sale and Workforce Reduction
ClearOne, Inc. has secured a $3 million convertible note from First Finance Ltd. to fund a strategic shift towards an asset sale and workforce reduction, while also regaining compliance with Nasdaq's minimum bid price requirement.
NASDAQ
CLRO
Clearone INCClearOne, Inc. has announced a 1-for-15 reverse stock split, effective June 9, 2025, to increase its per share market price and regain compliance with Nasdaq's minimum bid price requirement, following approval at a special shareholder meeting.
NASDAQ
CLRO
Clearone INCClearOne plans a 1-for-15 reverse stock split, pending stockholder approval, to increase its stock price and regain compliance with Nasdaq's minimum bid price requirement.
NASDAQ
CLRO
Clearone INC8-K: ClearOne Reports Disappointing Q1 2025 Results Amidst Cash Flow Constraints and Production Shortages
ClearOne's Q1 2025 revenue declined 36% year-over-year due to production shortages and cash flow constraints, leading to a larger net loss despite cost optimization efforts.
NASDAQ
CLRO
Clearone INCClearOne's Q4 2024 results show a sequential revenue increase and improved gross margins, but a year-over-year revenue decline and a significant drop in cash reserves highlight ongoing challenges.
NASDAQ
CLRO
Clearone INCClearOne, Inc. has entered into a Securities Purchase Agreement with Edward D. Bagley, its largest stockholder, for a private placement of 2,000,000 shares of common stock at $0.50 per share, totaling $1 million.
NASDAQ
CLRO
Clearone INCClearOne Inc. filed Form 8937 with the IRS to correct 1099-DIV forms, clarifying that a special distribution was a return of capital, not an ordinary dividend.
NASDAQ
CLRO
Clearone INCClearOne, Inc. received a notification from Nasdaq regarding non-compliance with listing rules due to the delay of its 2024 annual meeting of stockholders.
NASDAQ
CLRO
Clearone INCClearOne has been granted a 180-day extension by Nasdaq to regain compliance with the minimum bid price requirement, extending the deadline to June 16, 2025.
NASDAQ
CLRO
Clearone INCClearOne Inc. has granted incentive stock options to its CEO and CFO as part of their 2024 compensation and as retention incentives during a potential strategic transaction.